[
    "\nCELL CULTURE AND TRANSFECTION",
    {
        "title": "1)",
        "body": "Maintain routine passage of HEK293 cells in 10 cm tissue culture plates or 75 cm<sup>2</sup> flasks using MEM supplemented with 10% fetal bovine serum, 100 IU/mL penicillin and 100 IU/mL streptomycin."
    },
    {
        "title": "2)",
        "body": "On Day 1, passage 90% confluent HEK293 cells into 6-well tissue culture plates at a seeding density that will attain approximately 50% confluence within 24 hours. \r\n\n\nCRITICAL STEP:  Each well of a 6-well plate will yield sufficient cells for six assay wells in a 96-well plate.  For small experiments, one or two wells of a 6-well plate can be transfected with each reporter.  Transfecting two wells with each reporter allows identically transfected cells to be labeled with FlAsH-EDT<sub>2</sub> Labeling Reagent for intramolecular FlAsH BRET or left unlabeled for determining background BRET \\(see FlAsH labeling the tetracysteine tag)."
    },
    {
        "title": "3)",
        "body": "On Day 2, transfect 50% confluent cells with one Rluc-arrestin3-FlAsH expression plasmid in each well along with the GPCR of interest: \r\n\n\n\\(i)  For each transfection, combine 94 μL of plain MEM with 6 μL of FuGENE® HD transfection reagent in a sterile plastic 1.5 mL microfuge tube.  Vortex to mix and pulse in a microfuge.  \r\n\n\n\\(ii)  Allow to stand for 5 min at room temperature.\r\n\n\n\\(iii)  Add 1.0-1.5 μg of cDNA expression plasmid encoding the untagged GPCR of interest and 100-300 ng of one Rluc-arrestin3-FlAsH expression plasmid to each tube.  Flick tubes to mix and pulse in a microfuge. \r\n\n\nCRITICAL STEP: The optimal ratio of GPCR and Rluc-arrestin3-FlAsH expression plasmids needs to be determined empirically \\(see ANTICIPATED RESULTS).  \r\n\n\n\\(iv)  Allow the transfection mixture to stand at room temperature for 15 min.\r\n\n\n\\(v)  Add the transfection mixtures to each well of a 6-well plate and return cells to the tissue culture incubator.  \r\n\n\n\\(vi)  Allow cells to incubate at 37 ˚C overnight."
    },
    {
        "title": "4)",
        "body": "On Day 3, aspirate growth medium containing the transfection reagent from cells and discard.  Replace with 2 mL/well of MEM supplemented with 10% FBS, 100 IU/mL penicillin and 100 IU/mL streptomycin and return cells to incubator.  Allow cells to incubate at 37 ˚C overnight.  Cells will be labeled on Day 4 after attaining 90% confluence.\r\n\n\n\r\n\n\nFlAsH LABELING THE TETRACYSTEINE TAG"
    },
    {
        "title": "5)",
        "body": "On Day 4, aspirate growth medium from cells and discard. Wash monolayers 1X with DPBS to remove serum."
    },
    {
        "title": "6)",
        "body": "Detach cells by adding 1 mL of DPBS containing 2 mM EDTA to each well.  Gently pipette cells and transfer to 1.5 mL microfuge tubes."
    },
    {
        "title": "7)",
        "body": "Centrifuge at 3,000 x g in a variable speed microcentrifuge for 3 min to pellet cells.  Aspirate and discard the supernatant. Resuspend the cell pellet in 500 μL of HBSS.  \r\n\n\nCRITICAL STEP: Gently triturate several times using a 100-1000 μl single channel pipette to evenly disperse cells without lysing them."
    },
    {
        "title": "8)",
        "body": "Label the tetracysteine tag with FlAsH-EDT<sub>2</sub> Labeling Reagent from the TC-FlAsHTM In-Cell Tetracysteine Tag Detection Kit or leave the cells unlabeled for determining background BRET.\r\n\n\nCRITICAL STEP:  If more than six identically transfected 96-well plate wells are needed for a given experiment, it is best to combine cells from two \\(or more) transfected 6-well plate wells at this step to ensure equal expression of receptor and reporter, and then divide into 500 μl aliquots as needed for labeling.  \r\n\n\n\r\n\n\n\\(A)  To label the tetracysteine tag with FlAsH-EDT<sub>2</sub> Labeling Reagent:\r\n\n\n\\(i)  Add 0.67 μL \\(2.5 μM final concentration) of FlAsH-EDT<sub>2</sub> Labeling Reagent from the TC-FlAsH<sup>TM</sup> In-Cell Tetracysteine Tag Detection Kit to each microfuge tube.  Gently invert tubes 4-5 times to mix.  \r\n\n\nCRITICAL STEP:  The optimal labeling conditions need to be determined empirically.  The final concentration of FlAsH-EDT<sub>2</sub> Labeling Reagent may vary from 1-10 μM and labeling time from 30-60 min.  For labeling Rluc-arrestin3-FlAsH proteins in detached HEK293 cells we find that using 2.5 μM final concentration FlAsH-EDT<sub>2</sub> Labeling Reagent and labeling for 30 min gives consistent results.\r\n\n\nCAUTION: The FlAsH-EDT<sub>2</sub> Labeling Reagent is a bi-arsenical compound and toxic.  Wear appropriate personal protective equipment when handling and discard used solutions as specified by your Institutional guidelines for toxic waste.\r\n\n\n\\(ii)  Incubate at room temperature in the dark for 30 min.\r\n\n\n\\(iii) Centrifuge at 3,000 x g in a variable speed microfuge for 3 min to pellet cells.  Aspirate and discard the labeling medium.  \r\n\n\n\\(iv)  Resuspend cells in 1 mL of room temperature 1X BAL Wash Buffer diluted from the 100X stock with HBSS just prior to use. \r\n\n\nCRITICAL STEP: Gently triturate several times using a 100-1000 μl single channel pipette to evenly disperse cells without lysing them.\r\n\n\n\\(v)  Centrifuge at 3,000 x g in a variable speed microfuge for 3 min to pellet cells.  Aspirate and discard the wash buffer.  \r\n\n\n\\(vi)  Resuspend cells in 650 μL of BRET buffer.\r\n\n\nCRITICAL STEP: Gently triturate several times using a 100-1000 μl single channel pipette to evenly disperse cells without lysing them.\r\n\n\n\r\n\n\n\\(B) Background BRET is determined by measuring the BRET ratio observed in cells lacking the acceptor, i.e. fluorescent arsenical.  To prepare cells for measuring background BRET treat one 500 μL aliquot of cells expressing each reporter \\(from Step"
    },
    {
        "title": "7)",
        "body": "exactly as described in Steps 8.A.i-v except for omitting the FlAsH-EDT<sub>2</sub> Labeling Reagent from Step 8.A.i.\r\n\n\nCRITICAL STEP: When performing experiments comparing vehicle versus ligand stimulation of identically transfected cells, it may be satisfactory to omit the measurement of background BRET and calculate ligand-induced Δ BRET instead of Δ Net BRET.  If quantitative comparisons between different transfections are planned, e.g. a wild type versus a mutated GPCR, determining background BRET for each transfection condition is critical as background may vary between transfections."
    },
    {
        "title": "9)",
        "body": [
            "Transfer 100 μL of cells suspended in BRET buffer to each well of an opaque white 96-well plate \\(approximately 1.5 x 105 cells/well) following the pre-determined layout of the experimental plate map \\(FIGURE 2",
            {
                "title": "2).",
                "body": "CRITICAL STEP: The optimal cell number per well will vary somewhat between different plate readers and must be determined empirically in pilot assays."
            }
        ]
    },
    {
        "title": "10)",
        "body": "Wrap the experimental plate in aluminum foil and keep it in the dark at room temperature until ready to perform the experiment.\r\n\n\n\r\n\n\nPREPARING THE DRUG PLATE"
    },
    {
        "title": "11)",
        "body": "Prepare vehicle and ligand solutions during the 30 min FlAsH labeling period.  Dilute ligand stocks to 12X desired final concentration in BRET buffer.  Prepare non-stimulated controls using the same dilution of ligand vehicle in BRET buffer.\r\n\n\nCRITICAL STEP:  The most consistent Rluc-arrestin3-FlAsH BRET profiles are obtained when the maximum fraction of reporter is GPCR-bound, so stimulations are usually carried out at saturating ligand concentration.  It is helpful to perform an initial ligand concentration-response curve to determine the ligand dose that gives the maximum Δ Net BRET signal \\(see ANTICIPATED RESULTS)."
    },
    {
        "title": "12)",
        "body": [
            "Aliquot ~15 μL of 12X ligand per experimental well into PCR tube strips or round bottom 96-well drug plates, whichever is more convenient.  Stimulations will be carried out using a multi-channel pipettor to transfer ligand one row at a time so the drug plate must be laid out in a grid corresponding to the experimental plate \\(FIGURE",
            {
                "title": "2).",
                "body": "CRITICAL STEP: If using a microplate reader equipped with dual auto-injectors, it is necessary to prepare both ligands and coelenterazine in 96-well plates.\r\n\n\n\r\n\n\nMEASURING INTRAMOLECULAR FlAsH BRET"
            }
        ]
    },
    {
        "title": "13)",
        "body": "Dilute the 2.2 mM stock coelenterazine solution to 12X desired final concentration \\(60 μM) in BRET buffer.  Once added to the cell plate the final coelenterazine concentration will be 5 μM.   Transfer the 12X solution into PCR tube strips or round bottom 96-well drug plates for dispensing with a multi-channel pipettor.  \r\n\n\nCRITICAL STEP: Coelenterazine is susceptible to light and rapid oxidation.  Prepare the working solution just before use and protect from light until needed."
    },
    {
        "title": "14)",
        "body": "Using an appropriate multi-mode plate reader, verify Rluc-arrestin3-FlAsH expression and tetracysteine tag labeling by directly measuring TC-FlAsH fluorescence with an excitation wavelength of 485 nm and emission wavelength of 530 nm."
    },
    {
        "title": "15)",
        "body": "Using a 1-20 ul multi-channel pipettor transfer 10 μL of 12X ligand from the PCR tube strips or round bottom 96-well drug plate to the corresponding wells in the experimental plate.  Pipette up and down several times to ensure mixing.  \r\n\n\nCRITICAL STEP: Change pipette tips between rows to avoid mixing ligands or cells expressing different reporters."
    },
    {
        "title": "16)",
        "body": "Pre-incubate cells with ligand for 0-10 min at room temperature before adding coelenterazine.\r\n\n\nCRITICAL STEP: Both the time and temperature of ligand stimulation are relevant variables and should be determined empirically \\(see ANTICIPATED RESULTS). When performing a time course experiment, stagger the time of addition of ligand to the wells and add coelenterazine to all wells simultaneously."
    },
    {
        "title": "17)",
        "body": "Using a 1-20 μl multi-channel pipettor transfer 10 μL of 12X coelenterazine solution from the PCR tube strips or round bottom 96-well drug plate to the corresponding wells in the experimental plate.  Pipette up and down several times to ensure mixing.  \r\n\n\nCRITICAL STEP: Change pipette tips between rows to avoid mixing ligands or cells expressing different reporters."
    },
    {
        "title": "18)",
        "body": "Return the experimental plate to the plate reader and allow 2 min for the Rluc emission to stabilize, then record 6 consecutive 1 sec readings of Rluc \\(485 nm) luminescence and TC FlAsH fluorescence \\(530 nm; YFP setting) at 1 min intervals.  Total read time is 5 min, beginning 2 min after the addition of coelenterazine.\r\n\n\n\r\n\n\nDATA ANALYSIS AND INTERPRETATION"
    },
    {
        "title": "19)",
        "body": "The BRET ratio is the TC FlAsH fluorescence signal \\(530 nm) over the Rluc signal \\(485 nm) measured simultaneously.  The instrument software of multi-mode plate readers will automatically calculate the BRET ratio.  Export the BRET ratio data as a Microsoft Excel spreadsheet."
    },
    {
        "title": "20)",
        "body": "Using Microsoft Excel, determine the mean of the 6 consecutive reads to obtain the average BRET ratio for each well \\(EQUATION 1)."
    },
    {
        "title": "21)",
        "body": "Calculate the Net BRET ratio for each well by subtracting the mean background BRET ratio measured in cells in the same experiment that lack the BRET acceptor, i.e. were not labeled with FlAsH-EDT2, from the mean BRET ratio observed in FlAsH-EDT2 labeled cells \\(EQUATION 2)."
    },
    {
        "title": "22)",
        "body": [
            "Determine the Δ Net BRET for each ligand-stimulated condition relative to vehicle-stimulated in the same experiment. The Δ Net BRET is the Net BRET ratio obtained in stimulated cells minus the Net BRET ratio measured in cells exposed to vehicle only \\(EQUATION",
            {
                "title": "3).",
                "body": "This ratio represents the change in Net BRET occurring upon ligand stimulation, and is typically +/- 0.01-0.05 using our Rluc-arrestin3-FlAsH reporters \\(see ANTICIPATED RESULTS).  If duplicate or triplicate wells are used, a CV can be determined and the mean Δ Net BRET technical replicates on the plate can be used as a datum for determining the mean Δ Net BRET across multiple biological replicates of the experiment."
            }
        ]
    },
    {
        "title": "23)",
        "body": "The “conformational signature” of activated arrestin3 for any given GPCR-ligand combination can be displayed graphically by plotting the Δ Net BRET observed upon ligand stimulation for each of the six Rluc-arrestin3-FlAsH reporters \\(see ANTICIPATED RESULTS). \r\n\n\nCRITICAL STEP: In our hands the observed Δ Net BRET for GPCR-stimulated change in Rluc-arrestin3-FlAsH BRET is reproducible enough that five to six biological replicates are sufficient to discern effects of +/- 0.01 with p<0.05."
    }
]